Mammalian IAP antibodies and diagnostic kits
US5919912A · kind A · utility
20Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 1995 |
| Grant date | Jul 6, 1999 |
| Priority date | — |
| Expiry date | Aug 4, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is substantially pure DNA encoding mammalian IAP polypeptides; substantially pure polypeptides; and methods of using such DNA to express the IAP polypeptides in cells and animals to inhibit apoptosis. Also disclosed are conserved regions characteristic of the IAP family and primers and probes for the identification and isolation of additional IAP genes. In addition, methods for treating diseases and disorders involving apoptosis are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.